Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eukaryotic Initiation Factor-3 | 4 | 2020 | 50 | 1.890 |
Why?
|
Peptide Chain Initiation, Translational | 3 | 2016 | 100 | 1.390 |
Why?
|
Vesiculovirus | 2 | 2014 | 55 | 0.870 |
Why?
|
RNA Caps | 1 | 2016 | 73 | 0.530 |
Why?
|
Protein Biosynthesis | 2 | 2020 | 2100 | 0.530 |
Why?
|
Nucleotidyltransferases | 5 | 2020 | 244 | 0.480 |
Why?
|
Ribosome Subunits, Large, Eukaryotic | 1 | 2012 | 8 | 0.430 |
Why?
|
Stress, Physiological | 1 | 2020 | 1403 | 0.430 |
Why?
|
Down-Regulation | 2 | 2019 | 2915 | 0.390 |
Why?
|
Gene Expression Regulation, Viral | 2 | 2012 | 433 | 0.370 |
Why?
|
Virus Internalization | 2 | 2014 | 497 | 0.360 |
Why?
|
Ribosomal Proteins | 1 | 2012 | 370 | 0.350 |
Why?
|
RNA, Messenger | 2 | 2015 | 12758 | 0.320 |
Why?
|
Glucose | 1 | 2020 | 4345 | 0.310 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3419 | 0.300 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1890 | 0.290 |
Why?
|
Host-Pathogen Interactions | 2 | 2014 | 1454 | 0.260 |
Why?
|
Virus Replication | 1 | 2014 | 2427 | 0.260 |
Why?
|
Nematocyst | 1 | 2020 | 1 | 0.180 |
Why?
|
Sea Anemones | 1 | 2020 | 15 | 0.180 |
Why?
|
Calcium Channels, N-Type | 1 | 2020 | 43 | 0.180 |
Why?
|
Apoferritins | 1 | 2019 | 16 | 0.170 |
Why?
|
Crystallography, X-Ray | 4 | 2019 | 1989 | 0.170 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2019 | 94 | 0.160 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2019 | 61 | 0.160 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2019 | 122 | 0.160 |
Why?
|
Naphthyridines | 1 | 2019 | 143 | 0.150 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9417 | 0.150 |
Why?
|
HEK293 Cells | 4 | 2020 | 4269 | 0.150 |
Why?
|
Helicobacter hepaticus | 2 | 2008 | 25 | 0.150 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2019 | 141 | 0.150 |
Why?
|
5' Untranslated Regions | 2 | 2019 | 253 | 0.150 |
Why?
|
Ciprofloxacin | 1 | 2019 | 312 | 0.140 |
Why?
|
Oligonucleotides | 1 | 2020 | 566 | 0.140 |
Why?
|
Bacteriophages | 1 | 2020 | 378 | 0.140 |
Why?
|
Genes, jun | 1 | 2016 | 69 | 0.140 |
Why?
|
Substrate Specificity | 3 | 2015 | 1790 | 0.140 |
Why?
|
Nucleotides | 1 | 2019 | 453 | 0.130 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2016 | 42 | 0.130 |
Why?
|
Anemone | 1 | 2015 | 2 | 0.130 |
Why?
|
Immunity, Innate | 4 | 2019 | 3045 | 0.130 |
Why?
|
Guanine Nucleotides | 1 | 2015 | 55 | 0.130 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2016 | 112 | 0.130 |
Why?
|
Models, Molecular | 5 | 2019 | 5433 | 0.120 |
Why?
|
Mechanotransduction, Cellular | 1 | 2020 | 528 | 0.120 |
Why?
|
Interferon Type I | 1 | 2019 | 557 | 0.120 |
Why?
|
Ribonucleosides | 1 | 2015 | 79 | 0.120 |
Why?
|
Binding, Competitive | 1 | 2016 | 1141 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2015 | 287 | 0.120 |
Why?
|
Immunity | 1 | 2020 | 994 | 0.110 |
Why?
|
Helicobacter Infections | 2 | 2008 | 387 | 0.110 |
Why?
|
Cell Line | 4 | 2019 | 15576 | 0.110 |
Why?
|
Protein Binding | 5 | 2020 | 9345 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1300 | 0.110 |
Why?
|
Bacterial Proteins | 3 | 2020 | 3842 | 0.110 |
Why?
|
Protein Subunits | 1 | 2016 | 942 | 0.100 |
Why?
|
Immunoprecipitation | 1 | 2015 | 876 | 0.100 |
Why?
|
Integrases | 1 | 2015 | 518 | 0.100 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2012 | 123 | 0.100 |
Why?
|
Protein Structure, Tertiary | 2 | 2016 | 3792 | 0.100 |
Why?
|
Thiazoles | 1 | 2019 | 1517 | 0.100 |
Why?
|
Cross-Linking Reagents | 1 | 2015 | 685 | 0.100 |
Why?
|
Second Messenger Systems | 3 | 2020 | 202 | 0.100 |
Why?
|
Membrane Proteins | 3 | 2019 | 7847 | 0.100 |
Why?
|
Ribosomes | 1 | 2015 | 500 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.100 |
Why?
|
Binding Sites | 3 | 2015 | 6051 | 0.090 |
Why?
|
Protein Engineering | 1 | 2014 | 548 | 0.090 |
Why?
|
Cell Survival | 1 | 2020 | 5780 | 0.090 |
Why?
|
NF-kappa B | 1 | 2019 | 2481 | 0.090 |
Why?
|
Herpesvirus 8, Human | 1 | 2012 | 255 | 0.090 |
Why?
|
Organ Specificity | 1 | 2015 | 1964 | 0.090 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2019 | 1836 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 724 | 0.090 |
Why?
|
Peroxisomes | 1 | 2010 | 68 | 0.080 |
Why?
|
Phosphorylation | 1 | 2020 | 8311 | 0.080 |
Why?
|
Immunoblotting | 1 | 2012 | 1646 | 0.080 |
Why?
|
Bacteria | 1 | 2020 | 2192 | 0.080 |
Why?
|
Phylogeny | 1 | 2016 | 2806 | 0.080 |
Why?
|
Urease | 1 | 2008 | 39 | 0.080 |
Why?
|
Vibrio cholerae | 1 | 2014 | 793 | 0.080 |
Why?
|
Arenaviruses, New World | 1 | 2008 | 35 | 0.070 |
Why?
|
Arenaviridae Infections | 1 | 2008 | 53 | 0.070 |
Why?
|
DNA | 3 | 2019 | 7196 | 0.070 |
Why?
|
Hepatitis, Chronic | 1 | 2007 | 52 | 0.070 |
Why?
|
HeLa Cells | 1 | 2012 | 3087 | 0.070 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 291 | 0.070 |
Why?
|
Amino Acid Sequence | 5 | 2020 | 13441 | 0.070 |
Why?
|
Hepatitis | 1 | 2008 | 228 | 0.070 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2639 | 0.060 |
Why?
|
Escherichia coli | 2 | 2015 | 4209 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3634 | 0.060 |
Why?
|
Macrophages | 1 | 2019 | 5758 | 0.060 |
Why?
|
Nucleic Acid Conformation | 2 | 2019 | 901 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 17629 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3607 | 0.050 |
Why?
|
Signal Transduction | 2 | 2020 | 23416 | 0.050 |
Why?
|
Saccharomyces cerevisiae | 1 | 2012 | 2674 | 0.050 |
Why?
|
Bacterial Toxins | 1 | 2007 | 925 | 0.050 |
Why?
|
Catalytic Domain | 2 | 2014 | 704 | 0.050 |
Why?
|
Transcriptional Activation | 1 | 2007 | 1755 | 0.050 |
Why?
|
Humans | 16 | 2020 | 760617 | 0.040 |
Why?
|
Vero Cells | 2 | 2012 | 481 | 0.040 |
Why?
|
Deoxyribonuclease I | 1 | 2020 | 224 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2015 | 10432 | 0.040 |
Why?
|
Dinucleoside Phosphates | 1 | 2019 | 68 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9476 | 0.040 |
Why?
|
Intestines | 1 | 2008 | 1909 | 0.040 |
Why?
|
Operon | 1 | 2019 | 372 | 0.040 |
Why?
|
Interferons | 2 | 2013 | 703 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11514 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2007 | 2821 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2014 | 2178 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16571 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20074 | 0.030 |
Why?
|
Symbiosis | 1 | 2019 | 294 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1230 | 0.030 |
Why?
|
Apoproteins | 1 | 2015 | 45 | 0.030 |
Why?
|
AT Rich Sequence | 1 | 2015 | 10 | 0.030 |
Why?
|
DNA, Superhelical | 1 | 2015 | 51 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2411 | 0.030 |
Why?
|
Transposases | 1 | 2015 | 104 | 0.030 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2013 | 25 | 0.030 |
Why?
|
Drug Resistance | 1 | 2019 | 1594 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3268 | 0.030 |
Why?
|
Biocatalysis | 1 | 2013 | 170 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2019 | 1015 | 0.030 |
Why?
|
Lymphoma, Primary Effusion | 1 | 2012 | 17 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2015 | 1229 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2015 | 1162 | 0.020 |
Why?
|
Animals | 8 | 2020 | 168201 | 0.020 |
Why?
|
Hepatocytes | 2 | 2010 | 1231 | 0.020 |
Why?
|
Liver | 1 | 2007 | 7512 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 3965 | 0.020 |
Why?
|
Mice | 5 | 2019 | 81368 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2012 | 444 | 0.020 |
Why?
|
Genome, Viral | 1 | 2012 | 665 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2008 | 245 | 0.020 |
Why?
|
Structural Homology, Protein | 1 | 2008 | 87 | 0.020 |
Why?
|
Helicobacter | 1 | 2008 | 111 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3007 | 0.020 |
Why?
|
Plasmids | 1 | 2012 | 2265 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2008 | 428 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4172 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2008 | 200 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22131 | 0.020 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2012 | 1348 | 0.020 |
Why?
|
DNA, Viral | 1 | 2012 | 2195 | 0.020 |
Why?
|
Mutation | 3 | 2019 | 30016 | 0.020 |
Why?
|
Viral Proteins | 1 | 2012 | 1799 | 0.020 |
Why?
|
Glycosylation | 1 | 2008 | 1098 | 0.010 |
Why?
|
Gene Deletion | 1 | 2012 | 2661 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14389 | 0.010 |
Why?
|
Tyrosine | 1 | 2008 | 1440 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6520 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18937 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2008 | 1463 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12421 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7402 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15908 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4137 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.010 |
Why?
|
Mitochondria | 1 | 2010 | 3619 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13635 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4533 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16967 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7583 | 0.010 |
Why?
|
Cytokines | 1 | 2008 | 7373 | 0.010 |
Why?
|
Male | 2 | 2008 | 360358 | 0.000 |
Why?
|
Female | 1 | 2007 | 392148 | 0.000 |
Why?
|
Concepts
(170)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_